Riskpilot← Back to searchSign inGet full accessNORKLINIKKEN SANDNES AS
ASActiveOrg 825876332Hoveveien 9, 4306 SandnesTraditional, complementary and alternative medicine activities · NACE 8696Est. 20201 employees
Revenue 2024
NOK 8,7M
+12% vs 2023
EBITDA margin
7.5%
-5% vs 2023
Equity ratio
21.7%
Financial strength
Net profit 2024
NOK 338K
-8% vs 2023
| Revenue | NOK 8,7M | +12% |
| EBITDA | NOK 655K | -5% |
| Net profit | NOK 338K | -8% |
| Total assets | NOK 1,9M | +33% |
| Equity | NOK 404K | -29% |
| Employees | 1 | — |
Legal name
NORKLINIKKEN SANDNES AS
Org number
825876332
Legal form
Aksjeselskap
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
30. oktober 2020
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Eierskap og drift av kiropraktor- og fysioterapiklinikk og alt som er naturlig forbundet, herunder å yte tjenester, selge produkter, drive treningssenter og lignende.
Address
Hoveveien 9, 4306 Sandnes
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 95 | 5 597 | 6 736 | 7 757 | 8 694 |
| Staff expenses | −2 | −480 | −548 | −597 | −651 |
| EBITDA | −56 | 305 | 407 | 687 | 655 |
| Depreciation & amort. | −5 | −179 | −192 | −192 | −192 |
| EBIT | −60 | 126 | 215 | 495 | 463 |
| Net financials | 0 | −24 | −36 | −19 | −3 |
| Profit before tax | −60 | 102 | 178 | 476 | 460 |
| Tax | −0 | 8 | 39 | 106 | 122 |
| Net profit | −60 | 93 | 139 | 369 | 338 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 934 | 1 320 | 1 353 | 1 398 | 1 865 |
| Equity | −36 | 58 | 197 | 566 | 404 |
| Long-term debt | 0 | 675 | 444 | 5 | 0 |
| Short-term debt | 970 | 587 | 712 | 826 | 1 461 |
| Total debt | 970 | 1 262 | 1 156 | 832 | 1 461 |
EBITDA margin
7.5%
This company
15.8%
Market median
-53% vs market
20202024
Equity ratio
21.7%
This company
38.2%
Market median
-43% vs market
20202024
Return on equity
83.6%
This company
18.4%
Market median
+354% vs market
20202024
Net profit margin
3.9%
This company
8.1%
Market median
-52% vs market
20202024
Asset turnover
4.66×
This company
1.12×
Market median
+316% vs market
20202024
Debt / equity
3.61×
This company
0.62×
Market median
-482% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-09-04 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
DB Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2023 | |
| Former (3) | ||
| Board of Directors | 2020 – 2023 | |
| Board of Directors | 2020 – 2023 | |
| Board of Directors | 2020 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2024 | |
| Company | 50% | 50% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Kiropraktor Daniel Dyrstad As
NORKLINIKKEN SANDNES AS Board members of NORKLINIKKEN SANDNES AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Daniel Bjelland Dyrstad | Chief Executive Officer | 0 companies |
| Eirik Larsen | Board of Directors | 0 companies |
| Mikal Dyrstad | Chairman | 0 companies |
| Anders Bernt Knudsen | Board of Directors | 0 companies |
| Christer Fardan Olsnes | Board of Directors | 0 companies |